NewsRoom Articles - Page 640 of 1256

ThursdayMay 30, 2019 9:06 am

San Antonio Home & Land Puts your Dream Home within Reach

San Antonio Home & Land makes designing, building and financing a custom home on your own land easier than ever The team has hundreds of readymade floorplans and the ability to design custom floorplans based on your family’s unique needs The San Antonio Home & Land team has expertise spanning from planning to reality, putting your dream home well within reach Dream. Design. Build. San Antonio Home & Land makes designing, building and financing a new custom home on your own land easier than ever! It’s natural to be nervous about pursuing your dream home, but the expert team at…

WednesdayMay 29, 2019 11:57 am

Wild West Crypto Show Discusses Rising Price of Bitcoin

Episode 61 of the Wild West Crypto Show featured industry experts The episode focused on the recent run-up in bitcoin price The show also featured information on STOs The latest episode of the Wild West Crypto Show – episode 61 – was recently signed, sealed and delivered. The compelling segment included discussions on the rise in bitcoin price and other key issues concerning the industry. Episode 61 featured hosts Drew Taylor and Brent Bates examining the latest cryptocurrency news with Jonathan Keim, communications director of CryptoCurrencyWire. The episode kicked off with a discussion about Flexa launching a global payment network…

WednesdayMay 29, 2019 11:31 am

South Africa Distribution Pact Expands Global Reach of Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The global hemp cannabidiol market is expected to top $22 billion worldwide by 2022, with CBD products comprising 25 percent of all cannabis sales Wildflower Brands is expanding the wellness reach of its cannabis products through a distribution pact with South African cannabis network provider Africann The company is also launching into Europe with a Polish network agreement through pharmaceutical distributor Two Towers Cannabis-based wellness brand champion Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) continues to expand the reach of its holistic plant product portfolio, inking an exclusive distribution agreement for the South African natural betterment market this month. The…

WednesdayMay 29, 2019 11:08 am

Genprex Inc. (NASDAQ: GNPX) Hires Top Pharmaceutical Branding Agency to Oversee Drug Naming Process for Lead Drug Candidate

Genprex, a clinical stage gene therapy company, will be utilizing the services of a leading pharmaceutical branding agency to oversee the naming process of its lead drug candidate, Oncoprex Addison Whitney has over 28 years of experience in the market, guiding pharmaceutical companies such as Merck, Celgene and Roche through the regulatory steps involved in the name approval process Oncoprex is an innovative immunogene therapy targeting non-small cell lung cancer Genprex Inc. (NASDAQ: GNPX), a clinical stage gene therapy company, recently reported that it has retained the services of leading pharmaceutical branding agency Addison Whitney to assist with the naming…

WednesdayMay 29, 2019 10:45 am

Beyond Meat Inc. (NASDAQ: BYND) to Release Financial Results for Q1 2019 in June

Beyond Meat’s financial results will be announced during a conference call scheduled for June 6 A live webcast will also be available via the company’s official website for investors interested in the financial information Beyond Meat’s portfolio of plant-based foods that replicate the taste and texture of meat has grown in popularity since the company’s launch in 2009, and its products are now available at more than 30,000 retail locations around the world Beyond Meat Inc. (NASDAQ: BYND), a leading provider of plant-based meat substitute products, recently announced that its financial results for the first quarter of 2019 will be…

WednesdayMay 29, 2019 10:10 am

INmune Bio Inc. (NASDAQ: INMB) is “One to Watch”

INmune Bio’s IPO closed February 1, 2019, with NASDAQ Capital Markets listing on February 4, 2019 Public clinical-stage immunology company with programs in oncology and neurodegenerative disease INmune Bio targets large markets with unsolved problems such as resistance to checkpoint inhibitor therapy, a fast-growing oncology market segment; MRD, the cause of cancer relapse; and neuroinflammation as a cause of Alzheimer’s disease Receiver of “Part the Cloud” $1 million grant awarded by Alzheimer’s Association Experienced leadership with extensive experience in the targeted fields of clinical research and drug development Intellectual property with multiple filings in process for INB03/XPro1595 and INKmune Insider…

WednesdayMay 29, 2019 9:00 am

Biotechs That Successfully Combat Cancer Could See Blockbuster Returns

NetworkNewsWire Editorial Coverage: Gene therapy is hot on the trail of killing cancer, and companies that deliver cures could see blockbuster returns. Pioneering a new paradigm in cancer therapeutics, Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) is leveraging its patented technology platform to deliver powerful tumor-suppressing genes directly into cancer cells. Calithera Biosciences Inc. (NASDAQ: CALA) is looking for cures for cancer and other life-threatening diseases by discovering, developing and commercializing novel, small-molecule drugs that target tumor and immune cell metabolism. Adaptimmune Therapeutics plc (NASDAQ: ADAP) is developing novel cancer immunotherapy products for cancer patients by engineering T-cells to target and destroy cancer. Agenus…

TuesdayMay 28, 2019 12:32 pm

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) Seeks to Transform Cannabis Beverage and Edibles Market with Water-Soluble Tech

Sproutly is a licensed producer with exclusive rights to Infusion Biosciences’ groundbreaking Aqueous Phytorecovery Process (“APP”) technology for naturally water-soluble cannabinoids The Canadian cannabis beverage market is estimated to exceed $4 billion by 2022 SRUTF executives were tapped to present APP technology at key cannabis conferences Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) is rapidly gaining positive exposure in the cannabis space as the company presents its proprietary APP technological platform at numerous key cannabis conferences in the U.S. and Canada. Sproutly executives most recently shared details of the APP process at the Canaccord Genuity Third Annual Cannabis Conference…

TuesdayMay 28, 2019 12:10 pm

Genprex Inc. (NASDAQ: GNPX) Pioneering an Innovative Cancer Therapy, Preclinical Data Shows Positive Results

Gene therapy could help overcome barriers that currently stand in the way of a cure for cancer Genprex is developing innovative, gene-based approaches toward the treatment of cancer, specifically non-small cell lung cancer Clinical trials so far have yielded encouraging data regarding the efficacy and safety of the company’s product candidate, Oncoprex Gene therapy could potentially advance the creation and delivery of effective cancer treatments in the years to come. Various companies are leading the way, and pioneers such as Genprex Inc. (NASDAQ: GNPX) are pushing for the introduction of innovative and targeted therapies that have the potential to help…

TuesdayMay 28, 2019 11:48 am

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Closes Financing, Proceeds Earmarked for Extraction Technology

Petroteq Energy completed a private placement of almost $1 million, generating funds that will be used to continue development of its proprietary technology for the environmentally-safe extraction of heavy oil Currently utilized at the Petroteq extraction facility in the Utah Asphalt Ridge pilot project, the technology could revolutionize the oil industry The company has already reported consistent production at the facility, with plans to expand capacity over the next 24 months Oil and gas industry technology innovator Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) recently announced the closing of a private placement generating aggregate gross proceeds of $985,950 for a…

Financial news and publishing for public and private companies

Contact us: 212.418.1217